Abstract
Glycosylation represents the most widespread posttranslational modifications, found in a broad spectrum of natural and therapeutic recombinant proteins. It highly affects bioactivity, site-specificity, stability, solubility, immunogenicity, and serum half-life of glycoproteins. Numerous expression hosts including yeasts, insect cells, transgenic plants, and mammalian cells have been explored for synthesizing therapeutic glycoproteins. However, glycosylation profile of eukaryotic expression systems differs from human. Glycosylation strategies have been proposed for humanizing the glycosylation pathways in expression hosts which is the main theme of this review. Besides, we also highlighted the glycosylation potential of protozoan parasites by emphasizing on the mammalian-like glycosylation potential of Leishmania tarentolae known as Leishmania expression system.
Similar content being viewed by others
References
Ablain J, Durand Ellen M, Yang S, Zhou Y, Zon Leonard I (2015) A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish. Dev Cell 32:756–764. doi:10.1016/j.devcel.2015.01.032
Alexandrov K, Grün M (2001) Protein expression systems for non-pathogenic Kinetoplastidae. Google Patents CA2388151 A1
Anyaogu DC, Mortensen UH (2015) Manipulating the glycosylation pathway in bacterial and lower eukaryotes for production of therapeutic proteins. Curr Opin Biotechnol 36:122–128
Aoki-Kinoshita KF (2013) Using databases and web resources for glycomics research. Mol Cell Proteomics 12:1036–1045
Aumiller JJ, Mabashi-Asazuma H, Hillar A, Shi X, Jarvis DL (2012) A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway. Glycobiology 22:417–428
Baghban R, Gargari SLM, Rajabibazl M, Nazarian S, Bakherad H (2016) Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris. Biotechnol Appl Biochem 63:200–205
Bazl MR et al (2007) Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells. Hybridoma 26:1–9
Böhm E et al (2015) Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells. BMC Biotechnol 15:1
Bosques CJ et al (2010) Chinese hamster ovary cells can produce galactose-[alpha]-1, 3-galactose antigens on proteins. Nat Biotechnol 28:1153–1156
Breitling R et al (2002) Non-pathogenic trypanosomatid protozoa as a platform for protein research and production. Protein Expr Purif 25:209–218
Breton C, Fournel-Gigleux S, Palcic MM (2012) Recent structures, evolution and mechanisms of glycosyltransferases. Curr Opin Struct Biol 22:540–549
Castilho A, Steinkellner H (2012) Glyco-engineering in plants to produce human-like N-glycan structures. Biotechnol J 7:1088–1098
Castilho A et al (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 285:15923–15930
Castilho A et al (2011) N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21:813–823
Chen C-Y, Lin C-Y, Chen G-Y, Hu Y-C (2011) Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv 29:618–631
Chen L, Yang X, Yuan H, Zhu L, Yue W (2014) [Construction and investigation of a recombinant eukaryotic expression vector for expressing the ORF3 protein of hepatitis E virus in BHK-21 fibroblasts]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese J Hepatol 22:499–503
Cheon SA, Kim H, Oh D-B, Kwon O, Kang HA (2012) Remodeling of the glycosylation pathway in the methylotrophic yeast Hansenula polymorpha to produce human hybrid-type N-glycans. J Microbiol 50:341–348
Choi B-K et al (2012) Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris. Appl Microbiol Biotechnol 95:671–682
Chung CH et al (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1, 3-galactose. N Engl J Med 358:1109–1117
Cox KM et al (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 24:1591–1597
Czarnota A, Tyborowska J, Peszyńska-Sularz G, Gromadzka B, Bieńkowska-Szewczyk K, Grzyb K (2016) Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus. Microb Cell Fact 15:1
Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA (2014) Emerging principles for the therapeutic exploitation of glycosylation. Science 343:1235681
Damasceno LM, Huang C-J, Batt CA (2012) Protein secretion in Pichia pastoris and advances in protein production. Appl Microbiol Biotechnol 93:31–39
Davies J, Jiang L, Pan LZ, LaBarre MJ, Anderson D, Reff M (2001) Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII. Biotechnol Bioeng 74:288–294
Dean N (1999) Asparagine-linked glycosylation in the yeast Golgi. Biochim Biophys Acta (BBA)-Gen Subj 1426:309–322
DiCarlo JE, Norville JE, Mali P, Rios X, Aach J, Church GM (2013) Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 41:4336–4343
Faye L, Boulaflous A, Benchabane M, Gomord V, Michaud D (2005) Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine 23:1770–1778
Ferrara C, Brünker P, Suter T, Moser S, Püntener U, Umaña P (2006) Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous β1, 4-N-acetylglucosaminyltransferase III and Golgi α-mannosidase II. Biotechnol Bioeng 93:851–861
Fujiyama K, Furukawa A, Katsura A, Misaki R, Omasa T, Seki T (2007) Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human β (1, 4)-galactosyltransferase. Biochem Biophys Res Commun 358:85–91
Geisler C, Jarvis DL (2012) Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells. Metab Eng 14:642–652
Geisler C, Aumiller JJ, Jarvis DL (2008) A fused lobes gene encodes the processing β-N-acetylglucosaminidase in Sf9 cells. J Biol Chem 283:11330–11339
Ghaderi D, Taylor RE, Padler-Karavani V, Diaz S, Varki A (2010) Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nat Biotechnol 28:863–867
Gomord V, Faye L (2004) Posttranslational modification of therapeutic proteins in plants. Curr Opin Plant Biol 7:171–181
Gomord V, Chamberlain P, Jefferis R, Faye L (2005) Biopharmaceutical production in plants: problems, solutions and opportunities. Trends Biotechnol 23:559–565
Haile S, Papadopoulou B (2007) Developmental regulation of gene expression in trypanosomatid parasitic protozoa. Curr Opin Microbiol 10:569–577
Hamilton SR et al (2006) Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 313:1441–1443
Harrison RL, Jarvis DL (2006) Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce “mammalianized” recombinant glycoproteins. Adv Virus Res 68:159–191
Hashimoto K et al (2006) KEGG as a glycome informatics resource. Glycobiology 16:63R–70R
He T, Xu S, Zhang G, Nakanishi H, Gao X (2014) [Reconstruction of N-glycosylation pathway for producing human glycoproteins in Saccharomyces cerevisiae]. Wei sheng wu xue bao = Acta Microbiol Sin 54:509–516
Hennet T, Cabalzar J (2015) Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction. Trends Biochem Sci 40:377–384
Hirabayashi J (2004) Lectin-based structural glycomics: glycoproteomics and glycan profiling. Glycoconj J 21:35–40
Hou J, Tyo KE, Liu Z, Petranovic D, Nielsen J (2012) Metabolic engineering of recombinant protein secretion by Saccharomyces cerevisiae. FEMS Yeast Res 12:491–510
Ilgoutz SC, Zawadzki JL, Ralton JE, McConville MJ (1999) Evidence that free GPI glycolipids are essential for growth of Leishmania mexicana. EMBO J 18:2746–2755
Jacobs P, Callewaert N (2009) N-glycosylation engineering of biopharmaceutical expression systems. Curr Mol Med 9:774–800
Jin C, Bencúrová M, Borth N, Ferko B, Jensen-Jarolim E, Altmann F, Hantusch B (2006) Immunoglobulin G specifically binding plant N-glycans with high affinity could be generated in rabbits but not in mice. Glycobiology 16:349–357
Jin C et al (2008) A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology 18:235–241
Kawamura YI et al (2008) DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer. Gastroenterology 135(142–151):e143
Khan AH, Sadroddiny E (2015) Licensed monoclonal antibodies and associated challenges. Hum Antibodies 23:63–72. doi:10.3233/HAB-150286
Khan AH, Sadroddiny E (2016) Application of immuno-PCR for the detection of early stage cancer. Mol Cell Probes 30:106–112. doi:10.1016/j.mcp.2016.01.010
Kim YK, Kim KR, Kang DG, Jang SY, Kim YH, Cha HJ (2011) Expression of β-1, 4-galactosyltransferase and suppression of β-N-acetylglucosaminidase to aid synthesis of complex N-glycans in insect Drosophila S2 cells. J Biotechnol 153:145–152
Kim NY, Choi HS, Shin SH, Choi JY (2012) Short-hairpin RNA-mediated gene expression interference in Trichoplusia ni cells. J Microbiol Biotechnol 22:190–198
Klatt S, Rohe M, Alagesan K, Kolarich D, Konthur Z, Hartl D (2013) Production of glycosylated soluble amyloid precursor protein alpha (sAPPalpha) in Leishmania tarentolae. J Proteome Res. doi:10.1021/pr300693f
Koprivova A et al (2004) Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J 2:517–523
Kost TA, Condreay JP, Jarvis DL (2005) Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23:567–575
Krainer FW et al (2013) Knockout of an endogenous mannosyltransferase increases the homogeneity of glycoproteins produced in Pichia pastoris. Sci Rep 3:3279
Kushnir S, Cirstea IC, Basiliya L, Lupilova N, Breitling R, Alexandrov K (2011) Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae. Mol Biochem Parasitol 176:69–79
Lauc G, Zoldoš V (2010) Protein glycosylation: an evolutionary crossroad between genes and environment. Mol BioSyst 6:2373–2379
Lawrence SM et al (2001) Cloning and expression of human sialic acid pathway genes to generate CMP-sialic acids in insect cells. Glycoconj J 18:205–213
Li H, d’Anjou M (2009) Pharmacological significance of glycosylation in therapeutic proteins. Curr Opin Biotechnol 20:678–684
Liang X-H, Haritan A, Uliel S, Michaeli S (2003) Trans and cis splicing in trypanosomatids: mechanism, factors, and regulation. Eukaryot Cell 2:830–840
Lim Y, Wong NS, Lee YY, Ku SC, Wong DC, Yap MG (2010) Engineering mammalian cells in bioprocessing–current achievements and future perspectives. Biotechnol Appl Biochem 55:175–189
Limkul J, Iizuka S, Sato Y, Misaki R, Ohashi T, Ohashi T, Fujiyama K (2016) The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants. Plant Biotechnol J 14:1682–1694
Lin N, George HJ, Mascarenhas J, Collingwood TN, Kayser KJ, Achtien K (2015a) Method of producing human-like glycosylation pattern using cells deficient in glutamine synthase, CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1, 3-galactosyltransferase. Google Patents US8980583 B2
Lin N et al (2015b) Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression. Biotechnol Prog 31:334–346
Luk FC, Johnson TM, Beckers CJ (2008) N-linked glycosylation of proteins in the protozoan parasite Toxoplasma gondii. Mol Biochem Parasitol 157:169–178
Mabashi-Asazuma H, Shi X, Geisler C, Kuo C-W, Khoo K-H, Jarvis DL (2013) Impact of a human CMP-sialic acid transporter on recombinant glycoprotein sialylation in glycoengineered insect cells. Glycobiology 23:199–210
Mabashi-Asazuma H, Kuo C-W, Khoo K-H, Jarvis DL (2014) A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells. Glycobiology 24:325–340
Mabashi-Asazuma H, Kuo C-W, Khoo K-H, Jarvis DL (2015) Modifying an insect cell N-glycan processing pathway using CRISPR-Cas technology. ACS Chem Biol 10:2199–2208
Macher BA, Galili U (2008) The Galα 1, 3Galβ1, 4GlcNAc-R (α-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta (BBA)-Gen Subj 1780:75–88
Majors BS, Betenbaugh MJ, Pederson NE, Chiang GG (2008) Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-xL. Biotechnol Bioeng 101:567–578
Malphettes L et al (2010) Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies. Biotechnol Bioeng 106:774–783
Marchal I, Jarvis DL, Cacan R, Verbert A (2001) Glycoproteins from insect cells: sialylated or not? Biol Chem 382:151–159
Naegeli A et al (2014) Molecular analysis of an alternative N-glycosylation machinery by functional transfer from Actinobacillus pleuropneumoniae to Escherichia coli. J Biol Chem 289:2170–2179
Nagasu T et al (1992) Isolation of new temperature-sensitive mutants of Saccharomyces cerevisiae deficient in mannose outer chain elongation. Yeast 8:535–547
Nasab FP, Aebi M, Bernhard G, Frey AD (2013) A combined system for engineering glycosylation efficiency and glycan structure in Saccharomyces cerevisiae. Appl Environ Microbiol 79:997–1007
Nett JH et al (2011) A combinatorial genetic library approach to target heterologous glycosylation enzymes to the endoplasmic reticulum or the Golgi apparatus of Pichia pastoris. Yeast 28:237–252
Niimi T (2012) Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review. Recomb Gene Expr 824:307–315
Onitsuka M et al (2012) Enhancement of sialylation on humanized IgG-like bispecific antibody by overexpression of α2, 6-sialyltransferase derived from Chinese hamster ovary cells. Appl Microbiol Biotechnol 94:69–80
Paccalet T et al (2015) Synthesis of sialic acid in plants. Google Patents
Palmberger D, Ashjaei K, Strell S, Hoffmann-Sommergruber K, Grabherr R (2014) Minimizing fucosylation in insect cell-derived glycoproteins reduces binding to IgE antibodies from the sera of patients with allergy. Biotechnol J 9:1206–1214
Park SR et al (2014) Expression, glycosylation and function of recombinant anti-colorectal cancer mAb CO17-1A in SfSWT4 insect cells. Entomol Res 44:39–46
Parodi AJ (1993) N-glycosylation in trypanosomatid protozoa. Glycobiology 3:193–199
Pays E, Nolan DP (1998) Expression and function of surface proteins in Trypanosoma brucei. Mol Biochem Parasitol 91:3–36
Phan H-P, Sugino M, Niimi T (2009) The production of recombinant human laminin-332 in a Leishmania tarentolae expression system. Protein Expr Purif 68:79–84
Piirainen MA, de Ruijter JC, Koskela EV, Frey AD (2014) Glycoengineering of yeasts from the perspective of glycosylation efficiency. New Biotechnol 31:532–537
Pion C et al (2014) Characterization and immunogenicity in mice of recombinant influenza haemagglutinins produced in Leishmania tarentolae. Vaccine 32:5570–5576
Potgieter TI et al (2009) Production of monoclonal antibodies by glycoengineered Pichia pastoris. J Biotechnol 139:318–325. doi:10.1016/j.jbiotec.2008.12.015
Rahimpour A et al (2013) Engineering the cellular protein secretory pathway for enhancement of recombinant tissue plasminogen activator expression in Chinese hamster ovary cells: effects of CERT and XBP1s genes. J Microbiol Biotechnol 23:1116–1122
Rahimpour A, Ahani R, Najaei A, Adeli A, Barkhordari F, Mahboudi F (2016) Development of genetically modified Chinese hamster ovary host cells for the enhancement of recombinant tissue plasminogen activator expression Malaysian. J Med Sci 23:6–13
Rahmati M, Khan AH, Razavi S, Khorramizadeh MR, Rasaee MJ, Sadroddiny E (2016) Cloning and expression of human bone morphogenetic protein-2 gene in Leishmania tarentolae. Biocatal Agric Biotechnol 5:199–203. doi:10.1016/j.bcab.2016.01.006
Rahmatpour S et al (2016) Application of immuno-PCR assay for the detection of serum IgE specific to Bermuda allergen. Mol Cell Probes. doi:10.1016/j.mcp.2016.10.002
Raymond F et al (2011) Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species. Nucleic Acids Res 40:1131–1147
Rich JR, Withers SG (2009) Emerging methods for the production of homogeneous human glycoproteins. Nat Chem Biol 5:206–215
Saint-Jore-Dupas C, Faye L, Gomord V (2007) From planta to pharma with glycosylation in the toolbox. Trends Biotechnol 25:317–323
Samuelson J, Banerjee S, Magnelli P, Cui J, Kelleher DJ, Gilmore R, Robbins PW (2005) The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases. Proc Natl Acad Sci USA 102:1548–1553
Schuster M et al (2005) Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering. Cancer Res 65:7934–7941
Schuster M et al (2007) In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system. Biotechnol J 2:700–708
Shabani M, Hemmati S, Hadavi R, Amirghofran Z, Jeddi-Tehrani M, Rabbani H, Shokri F (2010) Optimization of gene transfection in murine myeloma cell lines using different transfection reagents. Avicenna J Med Biotechnol 2:123–130
Shin YJ, Chong YJ, Yang MS, Kwon TH (2011) Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Plant Biotechnol J 9:1109–1119
Shinkawa T et al (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278:3466–3473
Simpson L, Sbicego S, Aphasizhev R (2003) Uridine insertion/deletion RNA editing in trypanosome mitochondria: a complex business. RNA 9:265–276
Sinclair AM, Elliott S (2005) Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci 94:1626–1635
Smith GE, Summers M, Fraser M (1983) Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 3:2156–2165
Stanley P (2011) Golgi glycosylation. Cold Spring Harb Perspect Biol 3:a005199
Struwe WB, Pagel K, Benesch JL, Harvey DJ, Campbell MP (2016) GlycoMob: an ion mobility-mass spectrometry collision cross section database for glycomics. Glycoconj J 33:399–404
Sun T et al (2015) Functional knockout of FUT8 in Chinese hamster ovary cells using CRISPR/Cas9 to produce a defucosylated antibody. Eng Life Sci 15:660–666
Swiech K, Picanço-Castro V, Covas DT (2012) Human cells: new platform for recombinant therapeutic protein production. Protein Expr Purif 84:147–153
Theron CW, Labuschagné M, Gudiminchi R, Albertyn J, Smit MS (2014) A broad-range yeast expression system reveals Arxula adeninivorans expressing a fungal self-sufficient cytochrome P450 monooxygenase as an excellent whole-cell biocatalyst. FEMS Yeast Res 14:556–566
van Oers MM, Pijlman GP, Vlak JM (2015) Thirty years of baculovirus–insect cell protein expression: from dark horse to mainstream technology. J Gen Virol 96:6–23
von Horsten HH et al (2010) Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase. Glycobiology 20:1607–1618
Wildt S, Gerngross TU (2005) The humanization of N-glycosylation pathways in yeast. Nat Rev Microbiol 3:119–128
Xu X et al (2011) The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 29:735–741
Xu H, Guo H, Cheung IY, Cheung N-KV (2016) Antitumor efficacy of anti-GD2 IgG1 is enhanced by Fc glyco-engineering. Cancer Immunol Res 4:631–638
Yang Z et al (2015) Engineered CHO cells for production of diverse, homogeneous glycoproteins. Nat Biotechnol 33:842–844
Yin B et al (2015) Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation. Biotechnol Bioeng 112:2343–2351
Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30:1158–1170
Zoldoš V, Horvat T, Lauc G (2013) Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies. Curr Opin Chem Biol 17:34–40
Acknowledgements
This review is the outcome of financially non-supported in house study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Khan, A.H., Bayat, H., Rajabibazl, M. et al. Humanizing glycosylation pathways in eukaryotic expression systems. World J Microbiol Biotechnol 33, 4 (2017). https://doi.org/10.1007/s11274-016-2172-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11274-016-2172-7